Commission Regulation (EU) 2026/2309 of 16 October 2026 amending the Annex to Regulation (EU) No 231/2012 laying down specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council, as regards specifications for enzymatically produced steviol glycosides to include rebaudioside M produced via enzymatic conversion of highl
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
L_202602309EN.000101.fmx.xml Official Journal of the European Union EN L series 2026/2309 19.10.2026 COMMISSION REGULATION (EU) 2026/2309 of 16 October 2026 amending the Annex to Regulation (EU) No 231/2012 laying down specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council, as regards specifications for enzymatically produced steviol glycosides to include rebaudioside M produced via enzymatic conversion of highly purified rebaudioside A stevia leaf extract (E 960c(ii)) using the genetically modified yeast K. phaffii CGMCC 7539 (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives ( 1 ) , and in particular Article 14 thereof, Having regard to Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings ( 2 ) , and in particular Article 7(5) thereof, Whereas: (1) Commission Regulation (EU) No 231/2012 ( 3 ) lays down specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008. (2) The specifications for food additives may be updated in accordance with the common procedure referred to in Article 3(1) of Regulation (EC) No 1331/2008, either on the initiative of the Commission or following an application from a Member State or an interested party. (3) The currently authorised food additive ‘enzymatically produced steviol glycosides’ (E 960c) is included in the group ‘steviol glycosides (E960a-E960c)’ in Part C of Annex II to Regulation (EC) No 1333/2008. (4) Regulation (EU) No 231/2012 provides that ‘rebaudioside M produced via enzymatic conversion of highly purified rebaudioside A stevia leaf extracts’ (E 960c(ii)) is produced using UDP-glucosyltransferase and sucrose synthase enzymes produced by the genetically modified strains of E. coli (pPM294, pFAF170 and pSK401). (5) On 22 December 2022, an application was submitted to the Commission for the amendment of the specifications to include in the specifications for rebaudioside M produced via enzyme modification of steviol glycosides from stevia (E 960c(i)) rebaudioside M produced via enzyme-catalysed bioconversion using the genetically modified yeast K. phaffii CGMCC 7539. However, in the course of the risk assessment, the applicant revised its original proposal and requested the amendment of the specifications for rebaudioside M produced via enzymatic conversion of highly purified rebaudioside A stevia leaf extracts (E 960c(ii)) instead. The Commission made the application available to the Member States pursuant to Article 4 of Regulation (EC) No 1331/2008. (6) In the opinion published on 14 May 2025 ( 4 ) , the European Food Safety Authority (‘the Authority’) evaluated the safety of the proposed amendment of the specifications for rebaudioside M produced via enzyme-catalysed bioconversion using the genetically modified yeast K. phaffii CGMCC 7539. The Authority concluded that there is no safety concern with respect to the proposed amendment to the specifications of E 960c(i) or E 960c(ii) in the Annex to Regulation (EU) No 231/2012 related to the use of the new genetically modified strain K. phaffii CGMCC 7539 in the manufacturing process of the food additive Rebaudioside M produced via enzyme-catalysed bioconversion. The Authority considered that it is in the remit of the risk managers to decide whether the proposed changes in the specifications should result in an amendment of the already existing specifications of E 960c(i) or E 960c(ii). In addition, the Authority recommended introducing a specific entry for kaurenoic acid in the proposed specifications. (7) The Annex to Regulation (EU) No 231/2012 should therefore be amended accordingly. (8) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, HAS ADOPTED THIS REGULATION: Article 1 The Annex to Regulation (EU) No 231/2012 is amended in accordance with the Annex to this Regulation. Article 2 This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 16 October 2026. For the Commission The President Ursula VON DER LEYEN ( 1 ) OJ L 354, 31.12.2008, p. 16 , ELI: http://data.europa.eu/eli/reg/2008/1333/oj . ( 2 ) OJ L 354, 31.12.2008, p. 1 , ELI: http://data.europa.eu/eli/reg/2008/1331/oj . ( 3 ) Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council ( OJ L 83, 22.3.2012, p. 1 , ELI: http://data.europa.eu/eli/reg/2012/231/oj ). ( 4 ) EFSA Panel on Food Additives and Flavourings, ‘Safety of the proposed amendment of the specifications of the food additive E960c(i) or E960c(ii)’, in EFSA Journal , 2025;23:e9396, https://doi.org/10.2903/j.efsa.2025.9396 . ANNEX In the Annex to Regulation (EU) No 231/2012, the entry for E 960c(ii) REBAUDIOSIDE M PRODUCED VIA ENZYMATIC CONVERSION OF HIGHLY PURIFIED REBAUDIOSIDE A STEVIA LEAF EXTRACTS is amended as follows: (1) the specification ‘Definition’ is replaced by the following: ‘ Definition Rebaudioside M produced via enzymatic conversion of highly purified rebaudioside A stevia leaf extracts is a steviol glycoside composed predominantly of rebaudioside M with minor amounts of other steviol glycosides, such as rebaudioside A, rebaudioside B and rebaudioside D. Rebaudioside M is produced via enzymatic conversion of highly purified steviol glycoside rebaudioside A extracts (95 % steviol glycosides) obtained from Stevia rebaudiana Bertoni plant using UDP-glucosyltransferase and sucrose synthase enzymes produced by the genetically modified strains of E. coli (pPM294, pFAF170 and pSK401) or of K. phaffii (CGMCC 7539) that facilitate the transfer of glucose from sucrose and UDP-glucose to steviol glycosides via glycosidic bonds. After removal of the enzymes by solid–liquid separation and heat treatment, the purification involves concentration of the rebaudioside M by resin adsorption, followed by recrystallisation of the steviol glycosides resulting in a final product containing not less than 95 % of rebaudioside M. Viable cells of E. coli (pPM294, pFAF170 and pSK401) or K. phaffii (CGMCC 7539) and their DNA shall not be detected in the food additive.’ (2) in the specification ‘Purity’, the following entry is inserted after the entry for ‘Residual solvent’: ‘Kaurenoic acid Not more than 0,3 mg/kg (measured by liquid chromatography-mass spectrometry detection)’ ELI: http://data.europa.eu/eli/reg/2026/2309/oj ISSN 1977-0677 (electronic edition)
Related documents
- Commission Regulation (EU) 2026/2289 of 15 October 2026 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, deltamethrin, dodine, maleic hydrazide, pinoxaden and prothioconazole in or on certain products#1502665
- 7 U.S.C. § 1639b — Establishment of national bioengineered food disclosure standard#561578
- Commission Implementing Regulation (EU) 2026/2247 of 12 October 2026 renewing the approval of the active substance cis-tricos-9-ene for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council#1502704
- Commission Implementing Decision (EU) 2026/2252 of 12 October 2026 repealing Implementing Decision (EU) 2024/1283 postponing the expiry date of the approval of cis-tricos-9-ene for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council#1502712
- 7 U.S.C. § 6504 — National standards for organic production#560323
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive